Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome

Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome

BackgroundTreatment with Trastuzumab is associated with cardiotoxicity. If Trastuzumab could be administered in a safe manner to patients who develop a reduced left ventricular ejection fraction (EF) of < 50% remains poorly understood.ObjectiveTo evaluate the impact of a cardioncological appr...

Full description

Bibliographic Details
Main Authors: Iacopo Fabiani, Carlo Maria Cipolla, Nicola Colombo, Daniela Cardinale
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Pharmacology
Subjects:
trastuzumab
breast cancer
heart failure
ejection fraction
cardiotoxicity
systolic dysfunction
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01190/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.01190/full

Similar Items